A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey
- 1 August 1997
- journal article
- Published by Elsevier in Brain Research
- Vol. 766 (1-2) , 107-112
- https://doi.org/10.1016/s0006-8993(97)00531-3
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Riluzole and experimental parkinsonismNeuroReport, 1994
- Riluzole and experimental parkinsonismNeuroReport, 1994
- Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischaemiaNeuroscience Letters, 1992
- MPTP mechanisms of neurotoxicity and their implications for Parkinson's diseaseEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Further treatment with MPTP does not produce parkinsonism in marmosets showing behavioural recovery from motor deficits induced by an earlier exposure to the toxinNeuropharmacology, 1989
- Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTPNeuroscience Letters, 1989
- Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1986
- Deficits in behavioral initiation and execution processes in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonismNeuroscience Letters, 1985
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- ParkinsonismNeurology, 1967